nodes	percent_of_prediction	percent_of_DWPC	metapath
Topotecan—ABCG2—Rosuvastatin—atherosclerosis	0.145	0.189	CbGbCtD
Topotecan—ABCG2—Ezetimibe—atherosclerosis	0.145	0.189	CbGbCtD
Topotecan—ABCG2—Pravastatin—atherosclerosis	0.132	0.172	CbGbCtD
Topotecan—ABCB1—Ezetimibe—atherosclerosis	0.0522	0.0682	CbGbCtD
Topotecan—ABCB1—Simvastatin—atherosclerosis	0.0486	0.0634	CbGbCtD
Topotecan—ABCB1—Pravastatin—atherosclerosis	0.0475	0.062	CbGbCtD
Topotecan—ABCB1—Lovastatin—atherosclerosis	0.0475	0.062	CbGbCtD
Topotecan—CYP3A4—Rosuvastatin—atherosclerosis	0.0313	0.0408	CbGbCtD
Topotecan—CYP3A4—Ezetimibe—atherosclerosis	0.0313	0.0408	CbGbCtD
Topotecan—CYP3A4—Simvastatin—atherosclerosis	0.0291	0.038	CbGbCtD
Topotecan—CYP3A4—Lovastatin—atherosclerosis	0.0285	0.0372	CbGbCtD
Topotecan—CYP3A4—Pravastatin—atherosclerosis	0.0285	0.0372	CbGbCtD
Topotecan—Irinotecan—ALB—atherosclerosis	0.00133	1	CrCbGaD
Topotecan—Cramp muscle—Simvastatin—atherosclerosis	0.00118	0.00641	CcSEcCtD
Topotecan—Rhinitis—Rosuvastatin—atherosclerosis	0.00115	0.00623	CcSEcCtD
Topotecan—Pharyngitis—Rosuvastatin—atherosclerosis	0.00113	0.00616	CcSEcCtD
Topotecan—Cramp muscle—Pravastatin—atherosclerosis	0.00107	0.00579	CcSEcCtD
Topotecan—Infestation NOS—Ezetimibe—atherosclerosis	0.00106	0.00575	CcSEcCtD
Topotecan—Infestation—Ezetimibe—atherosclerosis	0.00106	0.00575	CcSEcCtD
Topotecan—Neuropathy peripheral—Lovastatin—atherosclerosis	0.00106	0.00575	CcSEcCtD
Topotecan—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.00104	0.00567	CcSEcCtD
Topotecan—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.00104	0.00564	CcSEcCtD
Topotecan—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.001	0.00544	CcSEcCtD
Topotecan—Neuropathy peripheral—Simvastatin—atherosclerosis	0.000989	0.00537	CcSEcCtD
Topotecan—Pharyngitis—Ezetimibe—atherosclerosis	0.000943	0.00512	CcSEcCtD
Topotecan—Weight increased—Pravastatin—atherosclerosis	0.000931	0.00506	CcSEcCtD
Topotecan—Angioedema—Rosuvastatin—atherosclerosis	0.000909	0.00494	CcSEcCtD
Topotecan—Stomatitis—Niacin—atherosclerosis	0.000903	0.00491	CcSEcCtD
Topotecan—Neuropathy peripheral—Pravastatin—atherosclerosis	0.000895	0.00486	CcSEcCtD
Topotecan—Sweating—Niacin—atherosclerosis	0.000889	0.00483	CcSEcCtD
Topotecan—Chills—Lovastatin—atherosclerosis	0.000869	0.00472	CcSEcCtD
Topotecan—Cough—Rosuvastatin—atherosclerosis	0.000868	0.00472	CcSEcCtD
Topotecan—Angiopathy—Ezetimibe—atherosclerosis	0.000862	0.00468	CcSEcCtD
Topotecan—Immune system disorder—Ezetimibe—atherosclerosis	0.000858	0.00466	CcSEcCtD
Topotecan—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000856	0.00465	CcSEcCtD
Topotecan—Alopecia—Lovastatin—atherosclerosis	0.000856	0.00465	CcSEcCtD
Topotecan—Arthralgia—Rosuvastatin—atherosclerosis	0.000847	0.0046	CcSEcCtD
Topotecan—Myalgia—Rosuvastatin—atherosclerosis	0.000847	0.0046	CcSEcCtD
Topotecan—Alopecia—Ezetimibe—atherosclerosis	0.00084	0.00456	CcSEcCtD
Topotecan—Haemoglobin—Niacin—atherosclerosis	0.000836	0.00454	CcSEcCtD
Topotecan—Rhinitis—Niacin—atherosclerosis	0.000834	0.00453	CcSEcCtD
Topotecan—Haemorrhage—Niacin—atherosclerosis	0.000832	0.00452	CcSEcCtD
Topotecan—Hypoaesthesia—Niacin—atherosclerosis	0.000828	0.0045	CcSEcCtD
Topotecan—Malnutrition—Ezetimibe—atherosclerosis	0.000827	0.00449	CcSEcCtD
Topotecan—Rhinitis—Pravastatin—atherosclerosis	0.000821	0.00446	CcSEcCtD
Topotecan—Back pain—Lovastatin—atherosclerosis	0.000816	0.00443	CcSEcCtD
Topotecan—Hypoaesthesia—Pravastatin—atherosclerosis	0.000815	0.00443	CcSEcCtD
Topotecan—Pharyngitis—Pravastatin—atherosclerosis	0.000813	0.00442	CcSEcCtD
Topotecan—Chills—Simvastatin—atherosclerosis	0.000813	0.00442	CcSEcCtD
Topotecan—Muscle spasms—Lovastatin—atherosclerosis	0.000811	0.0044	CcSEcCtD
Topotecan—Infection—Rosuvastatin—atherosclerosis	0.000807	0.00438	CcSEcCtD
Topotecan—Alopecia—Simvastatin—atherosclerosis	0.000801	0.00435	CcSEcCtD
Topotecan—Back pain—Ezetimibe—atherosclerosis	0.0008	0.00435	CcSEcCtD
Topotecan—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000796	0.00433	CcSEcCtD
Topotecan—Muscle spasms—Ezetimibe—atherosclerosis	0.000795	0.00432	CcSEcCtD
Topotecan—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000795	0.00432	CcSEcCtD
Topotecan—Ill-defined disorder—Lovastatin—atherosclerosis	0.000782	0.00425	CcSEcCtD
Topotecan—Angioedema—Lovastatin—atherosclerosis	0.000771	0.00419	CcSEcCtD
Topotecan—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000767	0.00417	CcSEcCtD
Topotecan—Anaemia—Ezetimibe—atherosclerosis	0.000764	0.00415	CcSEcCtD
Topotecan—Malaise—Lovastatin—atherosclerosis	0.00076	0.00413	CcSEcCtD
Topotecan—Muscle spasms—Simvastatin—atherosclerosis	0.000758	0.00412	CcSEcCtD
Topotecan—Angioedema—Ezetimibe—atherosclerosis	0.000756	0.00411	CcSEcCtD
Topotecan—Angiopathy—Niacin—atherosclerosis	0.000755	0.0041	CcSEcCtD
Topotecan—Leukopenia—Lovastatin—atherosclerosis	0.000755	0.0041	CcSEcCtD
Topotecan—Chills—Niacin—atherosclerosis	0.000747	0.00406	CcSEcCtD
Topotecan—Malaise—Ezetimibe—atherosclerosis	0.000746	0.00405	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00074	0.00402	CcSEcCtD
Topotecan—Alopecia—Niacin—atherosclerosis	0.000735	0.00399	CcSEcCtD
Topotecan—Chills—Pravastatin—atherosclerosis	0.000735	0.00399	CcSEcCtD
Topotecan—Ill-defined disorder—Simvastatin—atherosclerosis	0.000732	0.00398	CcSEcCtD
Topotecan—Paraesthesia—Rosuvastatin—atherosclerosis	0.000729	0.00396	CcSEcCtD
Topotecan—Anaemia—Simvastatin—atherosclerosis	0.000729	0.00396	CcSEcCtD
Topotecan—Malnutrition—Niacin—atherosclerosis	0.000724	0.00393	CcSEcCtD
Topotecan—Alopecia—Pravastatin—atherosclerosis	0.000724	0.00393	CcSEcCtD
Topotecan—Cough—Ezetimibe—atherosclerosis	0.000722	0.00392	CcSEcCtD
Topotecan—Angioedema—Simvastatin—atherosclerosis	0.000721	0.00392	CcSEcCtD
Topotecan—Arthralgia—Lovastatin—atherosclerosis	0.000718	0.0039	CcSEcCtD
Topotecan—Chest pain—Lovastatin—atherosclerosis	0.000718	0.0039	CcSEcCtD
Topotecan—Myalgia—Lovastatin—atherosclerosis	0.000718	0.0039	CcSEcCtD
Topotecan—Dyspepsia—Rosuvastatin—atherosclerosis	0.000715	0.00388	CcSEcCtD
Topotecan—Malaise—Simvastatin—atherosclerosis	0.000711	0.00386	CcSEcCtD
Topotecan—Discomfort—Lovastatin—atherosclerosis	0.000709	0.00385	CcSEcCtD
Topotecan—Leukopenia—Simvastatin—atherosclerosis	0.000706	0.00384	CcSEcCtD
Topotecan—Arthralgia—Ezetimibe—atherosclerosis	0.000704	0.00383	CcSEcCtD
Topotecan—Chest pain—Ezetimibe—atherosclerosis	0.000704	0.00383	CcSEcCtD
Topotecan—Myalgia—Ezetimibe—atherosclerosis	0.000704	0.00383	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000699	0.0038	CcSEcCtD
Topotecan—Muscle spasms—Niacin—atherosclerosis	0.000696	0.00378	CcSEcCtD
Topotecan—Discomfort—Ezetimibe—atherosclerosis	0.000696	0.00378	CcSEcCtD
Topotecan—Constipation—Rosuvastatin—atherosclerosis	0.000694	0.00377	CcSEcCtD
Topotecan—Pain—Rosuvastatin—atherosclerosis	0.000694	0.00377	CcSEcCtD
Topotecan—Anaphylactic shock—Lovastatin—atherosclerosis	0.000688	0.00374	CcSEcCtD
Topotecan—Muscle spasms—Pravastatin—atherosclerosis	0.000686	0.00372	CcSEcCtD
Topotecan—Infection—Lovastatin—atherosclerosis	0.000684	0.00371	CcSEcCtD
Topotecan—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000675	0.00367	CcSEcCtD
Topotecan—Thrombocytopenia—Lovastatin—atherosclerosis	0.000674	0.00366	CcSEcCtD
Topotecan—Arthralgia—Simvastatin—atherosclerosis	0.000672	0.00365	CcSEcCtD
Topotecan—Myalgia—Simvastatin—atherosclerosis	0.000672	0.00365	CcSEcCtD
Topotecan—Chest pain—Simvastatin—atherosclerosis	0.000672	0.00365	CcSEcCtD
Topotecan—Infection—Ezetimibe—atherosclerosis	0.000671	0.00364	CcSEcCtD
Topotecan—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000669	0.00364	CcSEcCtD
Topotecan—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000664	0.00361	CcSEcCtD
Topotecan—Discomfort—Simvastatin—atherosclerosis	0.000663	0.0036	CcSEcCtD
Topotecan—Nervous system disorder—Ezetimibe—atherosclerosis	0.000662	0.0036	CcSEcCtD
Topotecan—Angioedema—Niacin—atherosclerosis	0.000662	0.00359	CcSEcCtD
Topotecan—Ill-defined disorder—Pravastatin—atherosclerosis	0.000662	0.00359	CcSEcCtD
Topotecan—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000661	0.00359	CcSEcCtD
Topotecan—Anaemia—Pravastatin—atherosclerosis	0.000659	0.00358	CcSEcCtD
Topotecan—Anorexia—Lovastatin—atherosclerosis	0.000656	0.00356	CcSEcCtD
Topotecan—Skin disorder—Ezetimibe—atherosclerosis	0.000656	0.00356	CcSEcCtD
Topotecan—Angioedema—Pravastatin—atherosclerosis	0.000652	0.00354	CcSEcCtD
Topotecan—Leukopenia—Niacin—atherosclerosis	0.000648	0.00352	CcSEcCtD
Topotecan—Urticaria—Rosuvastatin—atherosclerosis	0.000645	0.0035	CcSEcCtD
Topotecan—Anaphylactic shock—Simvastatin—atherosclerosis	0.000644	0.0035	CcSEcCtD
Topotecan—Malaise—Pravastatin—atherosclerosis	0.000643	0.00349	CcSEcCtD
Topotecan—Abdominal pain—Rosuvastatin—atherosclerosis	0.000642	0.00349	CcSEcCtD
Topotecan—Infection—Simvastatin—atherosclerosis	0.00064	0.00347	CcSEcCtD
Topotecan—Leukopenia—Pravastatin—atherosclerosis	0.000638	0.00347	CcSEcCtD
Topotecan—Cough—Niacin—atherosclerosis	0.000632	0.00343	CcSEcCtD
Topotecan—Thrombocytopenia—Simvastatin—atherosclerosis	0.00063	0.00342	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000627	0.00341	CcSEcCtD
Topotecan—Cough—Pravastatin—atherosclerosis	0.000622	0.00338	CcSEcCtD
Topotecan—Paraesthesia—Lovastatin—atherosclerosis	0.000618	0.00336	CcSEcCtD
Topotecan—Arthralgia—Niacin—atherosclerosis	0.000617	0.00335	CcSEcCtD
Topotecan—Myalgia—Niacin—atherosclerosis	0.000617	0.00335	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000615	0.00334	CcSEcCtD
Topotecan—Anorexia—Simvastatin—atherosclerosis	0.000614	0.00333	CcSEcCtD
Topotecan—Dyspnoea—Lovastatin—atherosclerosis	0.000614	0.00333	CcSEcCtD
Topotecan—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000612	0.00333	CcSEcCtD
Topotecan—Chest pain—Pravastatin—atherosclerosis	0.000607	0.0033	CcSEcCtD
Topotecan—Myalgia—Pravastatin—atherosclerosis	0.000607	0.0033	CcSEcCtD
Topotecan—Arthralgia—Pravastatin—atherosclerosis	0.000607	0.0033	CcSEcCtD
Topotecan—Paraesthesia—Ezetimibe—atherosclerosis	0.000606	0.00329	CcSEcCtD
Topotecan—Dyspepsia—Lovastatin—atherosclerosis	0.000606	0.00329	CcSEcCtD
Topotecan—Dyspnoea—Ezetimibe—atherosclerosis	0.000602	0.00327	CcSEcCtD
Topotecan—Discomfort—Pravastatin—atherosclerosis	0.0006	0.00326	CcSEcCtD
Topotecan—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000598	0.00325	CcSEcCtD
Topotecan—Decreased appetite—Lovastatin—atherosclerosis	0.000598	0.00325	CcSEcCtD
Topotecan—Dyspepsia—Ezetimibe—atherosclerosis	0.000594	0.00323	CcSEcCtD
Topotecan—Fatigue—Lovastatin—atherosclerosis	0.000593	0.00322	CcSEcCtD
Topotecan—Anaphylactic shock—Niacin—atherosclerosis	0.000591	0.00321	CcSEcCtD
Topotecan—Constipation—Lovastatin—atherosclerosis	0.000589	0.0032	CcSEcCtD
Topotecan—Pain—Lovastatin—atherosclerosis	0.000589	0.0032	CcSEcCtD
Topotecan—Decreased appetite—Ezetimibe—atherosclerosis	0.000587	0.00319	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000587	0.00319	CcSEcCtD
Topotecan—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000583	0.00317	CcSEcCtD
Topotecan—Asthenia—Rosuvastatin—atherosclerosis	0.000583	0.00317	CcSEcCtD
Topotecan—Anaphylactic shock—Pravastatin—atherosclerosis	0.000582	0.00316	CcSEcCtD
Topotecan—Fatigue—Ezetimibe—atherosclerosis	0.000582	0.00316	CcSEcCtD
Topotecan—Infection—Pravastatin—atherosclerosis	0.000578	0.00314	CcSEcCtD
Topotecan—Paraesthesia—Simvastatin—atherosclerosis	0.000578	0.00314	CcSEcCtD
Topotecan—Pain—Ezetimibe—atherosclerosis	0.000577	0.00314	CcSEcCtD
Topotecan—Constipation—Ezetimibe—atherosclerosis	0.000577	0.00314	CcSEcCtD
Topotecan—Pruritus—Rosuvastatin—atherosclerosis	0.000575	0.00312	CcSEcCtD
Topotecan—Skin disorder—Niacin—atherosclerosis	0.000574	0.00312	CcSEcCtD
Topotecan—Dyspnoea—Simvastatin—atherosclerosis	0.000574	0.00312	CcSEcCtD
Topotecan—Hyperhidrosis—Niacin—atherosclerosis	0.000571	0.0031	CcSEcCtD
Topotecan—Thrombocytopenia—Pravastatin—atherosclerosis	0.00057	0.0031	CcSEcCtD
Topotecan—Feeling abnormal—Lovastatin—atherosclerosis	0.000567	0.00308	CcSEcCtD
Topotecan—Dyspepsia—Simvastatin—atherosclerosis	0.000567	0.00308	CcSEcCtD
Topotecan—Anorexia—Niacin—atherosclerosis	0.000563	0.00306	CcSEcCtD
Topotecan—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000563	0.00306	CcSEcCtD
Topotecan—Hyperhidrosis—Pravastatin—atherosclerosis	0.000563	0.00306	CcSEcCtD
Topotecan—Decreased appetite—Simvastatin—atherosclerosis	0.00056	0.00304	CcSEcCtD
Topotecan—Feeling abnormal—Ezetimibe—atherosclerosis	0.000556	0.00302	CcSEcCtD
Topotecan—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000556	0.00302	CcSEcCtD
Topotecan—Diarrhoea—Rosuvastatin—atherosclerosis	0.000556	0.00302	CcSEcCtD
Topotecan—Fatigue—Simvastatin—atherosclerosis	0.000555	0.00301	CcSEcCtD
Topotecan—Anorexia—Pravastatin—atherosclerosis	0.000555	0.00301	CcSEcCtD
Topotecan—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000552	0.003	CcSEcCtD
Topotecan—Constipation—Simvastatin—atherosclerosis	0.000551	0.00299	CcSEcCtD
Topotecan—Pain—Simvastatin—atherosclerosis	0.000551	0.00299	CcSEcCtD
Topotecan—Urticaria—Lovastatin—atherosclerosis	0.000547	0.00297	CcSEcCtD
Topotecan—Abdominal pain—Lovastatin—atherosclerosis	0.000544	0.00296	CcSEcCtD
Topotecan—Body temperature increased—Lovastatin—atherosclerosis	0.000544	0.00296	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000539	0.00293	CcSEcCtD
Topotecan—Dizziness—Rosuvastatin—atherosclerosis	0.000537	0.00292	CcSEcCtD
Topotecan—Urticaria—Ezetimibe—atherosclerosis	0.000536	0.00291	CcSEcCtD
Topotecan—Abdominal pain—Ezetimibe—atherosclerosis	0.000534	0.0029	CcSEcCtD
Topotecan—Body temperature increased—Ezetimibe—atherosclerosis	0.000534	0.0029	CcSEcCtD
Topotecan—Paraesthesia—Niacin—atherosclerosis	0.000531	0.00288	CcSEcCtD
Topotecan—Feeling abnormal—Simvastatin—atherosclerosis	0.00053	0.00288	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00053	0.00288	CcSEcCtD
Topotecan—Dyspnoea—Niacin—atherosclerosis	0.000527	0.00286	CcSEcCtD
Topotecan—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000526	0.00286	CcSEcCtD
Topotecan—Paraesthesia—Pravastatin—atherosclerosis	0.000523	0.00284	CcSEcCtD
Topotecan—Dyspepsia—Niacin—atherosclerosis	0.00052	0.00283	CcSEcCtD
Topotecan—Dyspnoea—Pravastatin—atherosclerosis	0.000519	0.00282	CcSEcCtD
Topotecan—Decreased appetite—Niacin—atherosclerosis	0.000514	0.00279	CcSEcCtD
Topotecan—Dyspepsia—Pravastatin—atherosclerosis	0.000512	0.00278	CcSEcCtD
Topotecan—Rash—Rosuvastatin—atherosclerosis	0.000512	0.00278	CcSEcCtD
Topotecan—Dermatitis—Rosuvastatin—atherosclerosis	0.000512	0.00278	CcSEcCtD
Topotecan—Urticaria—Simvastatin—atherosclerosis	0.000511	0.00278	CcSEcCtD
Topotecan—Gastrointestinal disorder—Niacin—atherosclerosis	0.00051	0.00277	CcSEcCtD
Topotecan—Abdominal pain—Simvastatin—atherosclerosis	0.000509	0.00276	CcSEcCtD
Topotecan—Body temperature increased—Simvastatin—atherosclerosis	0.000509	0.00276	CcSEcCtD
Topotecan—Headache—Rosuvastatin—atherosclerosis	0.000509	0.00276	CcSEcCtD
Topotecan—Hypersensitivity—Lovastatin—atherosclerosis	0.000507	0.00275	CcSEcCtD
Topotecan—Decreased appetite—Pravastatin—atherosclerosis	0.000506	0.00275	CcSEcCtD
Topotecan—Pain—Niacin—atherosclerosis	0.000505	0.00275	CcSEcCtD
Topotecan—Fatigue—Pravastatin—atherosclerosis	0.000502	0.00273	CcSEcCtD
Topotecan—Constipation—Pravastatin—atherosclerosis	0.000498	0.0027	CcSEcCtD
Topotecan—Pain—Pravastatin—atherosclerosis	0.000498	0.0027	CcSEcCtD
Topotecan—Hypersensitivity—Ezetimibe—atherosclerosis	0.000497	0.0027	CcSEcCtD
Topotecan—Asthenia—Lovastatin—atherosclerosis	0.000494	0.00268	CcSEcCtD
Topotecan—Pruritus—Lovastatin—atherosclerosis	0.000487	0.00265	CcSEcCtD
Topotecan—Asthenia—Ezetimibe—atherosclerosis	0.000484	0.00263	CcSEcCtD
Topotecan—Gastrointestinal pain—Niacin—atherosclerosis	0.000483	0.00263	CcSEcCtD
Topotecan—Nausea—Rosuvastatin—atherosclerosis	0.000482	0.00262	CcSEcCtD
Topotecan—Feeling abnormal—Pravastatin—atherosclerosis	0.00048	0.00261	CcSEcCtD
Topotecan—Pruritus—Ezetimibe—atherosclerosis	0.000478	0.00259	CcSEcCtD
Topotecan—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000476	0.00259	CcSEcCtD
Topotecan—Hypersensitivity—Simvastatin—atherosclerosis	0.000474	0.00258	CcSEcCtD
Topotecan—Diarrhoea—Lovastatin—atherosclerosis	0.000471	0.00256	CcSEcCtD
Topotecan—Urticaria—Niacin—atherosclerosis	0.00047	0.00255	CcSEcCtD
Topotecan—Abdominal pain—Niacin—atherosclerosis	0.000467	0.00254	CcSEcCtD
Topotecan—Body temperature increased—Niacin—atherosclerosis	0.000467	0.00254	CcSEcCtD
Topotecan—Urticaria—Pravastatin—atherosclerosis	0.000462	0.00251	CcSEcCtD
Topotecan—Asthenia—Simvastatin—atherosclerosis	0.000462	0.00251	CcSEcCtD
Topotecan—Diarrhoea—Ezetimibe—atherosclerosis	0.000462	0.00251	CcSEcCtD
Topotecan—Body temperature increased—Pravastatin—atherosclerosis	0.00046	0.0025	CcSEcCtD
Topotecan—Abdominal pain—Pravastatin—atherosclerosis	0.00046	0.0025	CcSEcCtD
Topotecan—Pruritus—Simvastatin—atherosclerosis	0.000455	0.00247	CcSEcCtD
Topotecan—Dizziness—Lovastatin—atherosclerosis	0.000455	0.00247	CcSEcCtD
Topotecan—Dizziness—Ezetimibe—atherosclerosis	0.000446	0.00242	CcSEcCtD
Topotecan—Diarrhoea—Simvastatin—atherosclerosis	0.00044	0.00239	CcSEcCtD
Topotecan—Vomiting—Lovastatin—atherosclerosis	0.000438	0.00238	CcSEcCtD
Topotecan—Hypersensitivity—Niacin—atherosclerosis	0.000436	0.00237	CcSEcCtD
Topotecan—Rash—Lovastatin—atherosclerosis	0.000434	0.00236	CcSEcCtD
Topotecan—Dermatitis—Lovastatin—atherosclerosis	0.000434	0.00236	CcSEcCtD
Topotecan—Headache—Lovastatin—atherosclerosis	0.000431	0.00234	CcSEcCtD
Topotecan—Vomiting—Ezetimibe—atherosclerosis	0.000429	0.00233	CcSEcCtD
Topotecan—Hypersensitivity—Pravastatin—atherosclerosis	0.000429	0.00233	CcSEcCtD
Topotecan—Dizziness—Simvastatin—atherosclerosis	0.000426	0.00231	CcSEcCtD
Topotecan—Rash—Ezetimibe—atherosclerosis	0.000426	0.00231	CcSEcCtD
Topotecan—Dermatitis—Ezetimibe—atherosclerosis	0.000425	0.00231	CcSEcCtD
Topotecan—Asthenia—Niacin—atherosclerosis	0.000424	0.0023	CcSEcCtD
Topotecan—Headache—Ezetimibe—atherosclerosis	0.000423	0.0023	CcSEcCtD
Topotecan—Pruritus—Niacin—atherosclerosis	0.000418	0.00227	CcSEcCtD
Topotecan—Asthenia—Pravastatin—atherosclerosis	0.000418	0.00227	CcSEcCtD
Topotecan—Pruritus—Pravastatin—atherosclerosis	0.000412	0.00224	CcSEcCtD
Topotecan—Vomiting—Simvastatin—atherosclerosis	0.000409	0.00222	CcSEcCtD
Topotecan—Nausea—Lovastatin—atherosclerosis	0.000409	0.00222	CcSEcCtD
Topotecan—Rash—Simvastatin—atherosclerosis	0.000406	0.0022	CcSEcCtD
Topotecan—Dermatitis—Simvastatin—atherosclerosis	0.000406	0.0022	CcSEcCtD
Topotecan—Diarrhoea—Niacin—atherosclerosis	0.000404	0.0022	CcSEcCtD
Topotecan—Headache—Simvastatin—atherosclerosis	0.000403	0.00219	CcSEcCtD
Topotecan—Nausea—Ezetimibe—atherosclerosis	0.000401	0.00218	CcSEcCtD
Topotecan—Diarrhoea—Pravastatin—atherosclerosis	0.000398	0.00216	CcSEcCtD
Topotecan—Dizziness—Niacin—atherosclerosis	0.000391	0.00212	CcSEcCtD
Topotecan—Dizziness—Pravastatin—atherosclerosis	0.000385	0.00209	CcSEcCtD
Topotecan—Nausea—Simvastatin—atherosclerosis	0.000382	0.00208	CcSEcCtD
Topotecan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CSF1R—atherosclerosis	0.000381	0.00786	CbGpPWpGaD
Topotecan—Vomiting—Niacin—atherosclerosis	0.000376	0.00204	CcSEcCtD
Topotecan—Rash—Niacin—atherosclerosis	0.000373	0.00202	CcSEcCtD
Topotecan—Dermatitis—Niacin—atherosclerosis	0.000372	0.00202	CcSEcCtD
Topotecan—Headache—Niacin—atherosclerosis	0.00037	0.00201	CcSEcCtD
Topotecan—Vomiting—Pravastatin—atherosclerosis	0.00037	0.00201	CcSEcCtD
Topotecan—Rash—Pravastatin—atherosclerosis	0.000367	0.00199	CcSEcCtD
Topotecan—Dermatitis—Pravastatin—atherosclerosis	0.000367	0.00199	CcSEcCtD
Topotecan—Headache—Pravastatin—atherosclerosis	0.000365	0.00198	CcSEcCtD
Topotecan—TOP1—Circadian rythm related genes—PPARG—atherosclerosis	0.00036	0.00743	CbGpPWpGaD
Topotecan—ABCG2—Fluoropyrimidine Activity—MTHFR—atherosclerosis	0.000359	0.0074	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	0.000356	0.00735	CbGpPWpGaD
Topotecan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG1—atherosclerosis	0.000353	0.00728	CbGpPWpGaD
Topotecan—ABCG2—Iron uptake and transport—HMOX1—atherosclerosis	0.000352	0.00727	CbGpPWpGaD
Topotecan—Nausea—Niacin—atherosclerosis	0.000351	0.00191	CcSEcCtD
Topotecan—Nausea—Pravastatin—atherosclerosis	0.000346	0.00188	CcSEcCtD
Topotecan—TOP1—Circadian rythm related genes—SERPINE1—atherosclerosis	0.000324	0.0067	CbGpPWpGaD
Topotecan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP7A1—atherosclerosis	0.00032	0.0066	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	0.000295	0.00609	CbGpPWpGaD
Topotecan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—atherosclerosis	0.000277	0.00571	CbGpPWpGaD
Topotecan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	0.000268	0.00553	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	0.000256	0.00529	CbGpPWpGaD
Topotecan—ABCG2—HIF-2-alpha transcription factor network—SERPINE1—atherosclerosis	0.000256	0.00528	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	0.000252	0.0052	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—HMOX1—atherosclerosis	0.00025	0.00516	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—MAPK8—atherosclerosis	0.000242	0.00499	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—EDN1—atherosclerosis	0.000236	0.00487	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	0.000232	0.0048	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	0.00022	0.00454	CbGpPWpGaD
Topotecan—CYP3A4—Estrogen metabolism—GSTM1—atherosclerosis	0.000219	0.00453	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	0.000213	0.0044	CbGpPWpGaD
Topotecan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP7A1—atherosclerosis	0.000203	0.00419	CbGpPWpGaD
Topotecan—CYP3A4—Oxidation by Cytochrome P450—CYP7A1—atherosclerosis	0.0002	0.00413	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	0.000199	0.00411	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—LEP—atherosclerosis	0.000192	0.00396	CbGpPWpGaD
Topotecan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	0.000188	0.00387	CbGpPWpGaD
Topotecan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	0.000186	0.00383	CbGpPWpGaD
Topotecan—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	0.000185	0.00382	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—NOS2—atherosclerosis	0.000179	0.00369	CbGpPWpGaD
Topotecan—ABCG2—HIF-2-alpha transcription factor network—VEGFA—atherosclerosis	0.000176	0.00363	CbGpPWpGaD
Topotecan—ABCB1—ABC-family proteins mediated transport—APOA1—atherosclerosis	0.000166	0.00344	CbGpPWpGaD
Topotecan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	0.000165	0.00341	CbGpPWpGaD
Topotecan—CYP3A4—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	0.000164	0.0034	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—IL17A—atherosclerosis	0.00016	0.00331	CbGpPWpGaD
Topotecan—TOP1—Circadian rythm related genes—IL6—atherosclerosis	0.000154	0.00319	CbGpPWpGaD
Topotecan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	0.000153	0.00317	CbGpPWpGaD
Topotecan—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	0.000152	0.00314	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—SERPINE1—atherosclerosis	0.00015	0.00311	CbGpPWpGaD
Topotecan—TOP1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	0.000148	0.00306	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—CD40—atherosclerosis	0.000142	0.00294	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000139	0.00288	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—HMOX1—atherosclerosis	0.000135	0.00279	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.000134	0.00276	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—AGTR1—atherosclerosis	0.00013	0.00269	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—EDN1—atherosclerosis	0.000127	0.00263	CbGpPWpGaD
Topotecan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	0.000114	0.00236	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—IL10—atherosclerosis	0.000109	0.00225	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—CD40LG—atherosclerosis	0.000109	0.00225	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.000106	0.00218	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—LEP—atherosclerosis	0.000104	0.00214	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—VEGFA—atherosclerosis	0.000103	0.00214	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—FASLG—atherosclerosis	0.000101	0.00209	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—NOS2—atherosclerosis	9.66e-05	0.00199	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	9.58e-05	0.00198	CbGpPWpGaD
Topotecan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	9.46e-05	0.00195	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—atherosclerosis	9.2e-05	0.0019	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—CYP7A1—atherosclerosis	8.74e-05	0.0018	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—CYP7A1—atherosclerosis	8.62e-05	0.00178	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—TRPV1—atherosclerosis	8.61e-05	0.00178	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ABCG5—atherosclerosis	8.29e-05	0.00171	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—atherosclerosis	8.13e-05	0.00168	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—CYP27A1—atherosclerosis	8.08e-05	0.00167	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—CYP27A1—atherosclerosis	7.96e-05	0.00164	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—LDLRAP1—atherosclerosis	7.68e-05	0.00159	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ABCG4—atherosclerosis	7.54e-05	0.00156	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ABCG8—atherosclerosis	7.22e-05	0.00149	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PLTP—atherosclerosis	7.22e-05	0.00149	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	6.97e-05	0.00144	CbGpPWpGaD
Topotecan—ABCG2—HIF-1-alpha transcription factor network—AKT1—atherosclerosis	6.6e-05	0.00136	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—IFNG—atherosclerosis	6.42e-05	0.00132	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ABCG8—atherosclerosis	6.26e-05	0.00129	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—LTA4H—atherosclerosis	6.26e-05	0.00129	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—CETP—atherosclerosis	6.14e-05	0.00127	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—CXCL8—atherosclerosis	5.97e-05	0.00123	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—IL1B—atherosclerosis	5.72e-05	0.00118	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ABCG1—atherosclerosis	5.71e-05	0.00118	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	5.62e-05	0.00116	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—atherosclerosis	5.59e-05	0.00115	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—PLAT—atherosclerosis	5.41e-05	0.00112	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	5.18e-05	0.00107	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	5.01e-05	0.00103	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ABCG1—atherosclerosis	4.95e-05	0.00102	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—VEGFA—atherosclerosis	4.84e-05	0.001	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—TRPV1—atherosclerosis	4.66e-05	0.000961	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—LCAT—atherosclerosis	4.65e-05	0.00096	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—FABP4—atherosclerosis	4.65e-05	0.00096	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—PLG—atherosclerosis	4.6e-05	0.000949	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—APOA4—atherosclerosis	4.57e-05	0.000943	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP7A1—atherosclerosis	4.49e-05	0.000926	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ABCG5—atherosclerosis	4.48e-05	0.000925	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—TGFB1—atherosclerosis	4.45e-05	0.000918	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	4.24e-05	0.000876	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	4.23e-05	0.000873	CbGpPWpGaD
Topotecan—ABCB1—Allograft Rejection—TNF—atherosclerosis	4.15e-05	0.000857	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—LDLRAP1—atherosclerosis	4.15e-05	0.000857	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CYP27A1—atherosclerosis	4.15e-05	0.000856	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—APOB—atherosclerosis	4.06e-05	0.000839	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PLA2G2A—atherosclerosis	3.93e-05	0.000811	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—APOA2—atherosclerosis	3.93e-05	0.000811	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ALOX5AP—atherosclerosis	3.93e-05	0.000811	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ALOX15—atherosclerosis	3.93e-05	0.000811	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PLTP—atherosclerosis	3.9e-05	0.000806	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ABCG5—atherosclerosis	3.88e-05	0.000802	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—LPA—atherosclerosis	3.75e-05	0.000774	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	3.66e-05	0.000756	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—BGN—atherosclerosis	3.63e-05	0.00075	CbGpPWpGaD
Topotecan—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	3.61e-05	0.000745	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—APOA5—atherosclerosis	3.59e-05	0.000742	CbGpPWpGaD
Topotecan—ABCB1—HIF-1-alpha transcription factor network—AKT1—atherosclerosis	3.57e-05	0.000737	CbGpPWpGaD
Topotecan—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	3.56e-05	0.000734	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PLA2G1B—atherosclerosis	3.46e-05	0.000714	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—PPARA—atherosclerosis	3.43e-05	0.000708	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—LTA4H—atherosclerosis	3.38e-05	0.000699	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ABCG8—atherosclerosis	3.38e-05	0.000699	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ALOX5—atherosclerosis	3.34e-05	0.00069	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—CETP—atherosclerosis	3.32e-05	0.000685	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—APOA1—atherosclerosis	3.22e-05	0.000664	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—atherosclerosis	3.04e-05	0.000627	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NAMPT—atherosclerosis	3e-05	0.000619	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—LIPC—atherosclerosis	2.98e-05	0.000615	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—APOC3—atherosclerosis	2.96e-05	0.000611	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—LDLR—atherosclerosis	2.94e-05	0.000607	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—PLAT—atherosclerosis	2.92e-05	0.000604	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CETP—atherosclerosis	2.87e-05	0.000593	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—SCARB1—atherosclerosis	2.75e-05	0.000568	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ABCG1—atherosclerosis	2.67e-05	0.000552	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	2.63e-05	0.000544	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—HMGCR—atherosclerosis	2.6e-05	0.000537	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	2.59e-05	0.000535	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	2.56e-05	0.000528	CbGpPWpGaD
Topotecan—ABCG2—Transmembrane transport of small molecules—ALB—atherosclerosis	2.55e-05	0.000526	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—FABP4—atherosclerosis	2.51e-05	0.000519	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—LCAT—atherosclerosis	2.51e-05	0.000519	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	2.49e-05	0.000513	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—APOA4—atherosclerosis	2.47e-05	0.00051	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP7A1—atherosclerosis	2.43e-05	0.000501	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PLTP—atherosclerosis	2.4e-05	0.000496	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	2.39e-05	0.000494	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ABCA1—atherosclerosis	2.32e-05	0.000478	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	2.29e-05	0.000474	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	2.26e-05	0.000467	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CYP27A1—atherosclerosis	2.24e-05	0.000463	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	2.2e-05	0.000454	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	2.19e-05	0.000453	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PLA2G2A—atherosclerosis	2.13e-05	0.000439	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ALOX5AP—atherosclerosis	2.13e-05	0.000439	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ALOX15—atherosclerosis	2.13e-05	0.000439	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—APOA2—atherosclerosis	2.13e-05	0.000439	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ABCG5—atherosclerosis	2.1e-05	0.000433	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ABCG8—atherosclerosis	2.08e-05	0.00043	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—LTA4H—atherosclerosis	2.08e-05	0.00043	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	2.05e-05	0.000423	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—LPA—atherosclerosis	2.03e-05	0.000419	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—HMOX1—atherosclerosis	1.99e-05	0.00041	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—BGN—atherosclerosis	1.96e-05	0.000405	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—APOA5—atherosclerosis	1.94e-05	0.000401	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—APOB—atherosclerosis	1.9e-05	0.000393	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PLA2G1B—atherosclerosis	1.87e-05	0.000386	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.85e-05	0.000383	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GSTM1—atherosclerosis	1.85e-05	0.000382	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—LPL—atherosclerosis	1.82e-05	0.000375	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ALOX5—atherosclerosis	1.81e-05	0.000373	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—GPX1—atherosclerosis	1.77e-05	0.000366	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.74e-05	0.000359	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CD36—atherosclerosis	1.73e-05	0.000357	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.65e-05	0.00034	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—MTHFR—atherosclerosis	1.64e-05	0.000338	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NAMPT—atherosclerosis	1.62e-05	0.000335	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—LIPC—atherosclerosis	1.61e-05	0.000332	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PPARA—atherosclerosis	1.61e-05	0.000332	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—APOC3—atherosclerosis	1.6e-05	0.00033	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—LDLR—atherosclerosis	1.59e-05	0.000328	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—AGT—atherosclerosis	1.56e-05	0.000321	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CETP—atherosclerosis	1.55e-05	0.000321	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—LCAT—atherosclerosis	1.55e-05	0.00032	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—FABP4—atherosclerosis	1.55e-05	0.00032	CbGpPWpGaD
Topotecan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.53e-05	0.000315	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—APOE—atherosclerosis	1.52e-05	0.000315	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—APOA4—atherosclerosis	1.52e-05	0.000314	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—CAV1—atherosclerosis	1.51e-05	0.000312	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—APOA1—atherosclerosis	1.51e-05	0.000311	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.49e-05	0.000308	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—SCARB1—atherosclerosis	1.49e-05	0.000307	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HMGCR—atherosclerosis	1.41e-05	0.00029	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.38e-05	0.000285	CbGpPWpGaD
Topotecan—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.38e-05	0.000284	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PIK3CG—atherosclerosis	1.38e-05	0.000284	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PPARG—atherosclerosis	1.33e-05	0.000274	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.31e-05	0.00027	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.31e-05	0.00027	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—APOA2—atherosclerosis	1.31e-05	0.00027	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.31e-05	0.00027	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—INS—atherosclerosis	1.3e-05	0.000269	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.29e-05	0.000267	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ABCA1—atherosclerosis	1.25e-05	0.000259	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—LPA—atherosclerosis	1.25e-05	0.000258	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—BGN—atherosclerosis	1.21e-05	0.00025	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—APOA5—atherosclerosis	1.2e-05	0.000247	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—ALB—atherosclerosis	1.19e-05	0.000246	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.15e-05	0.000238	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—NOS3—atherosclerosis	1.14e-05	0.000236	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.11e-05	0.00023	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—HMOX1—atherosclerosis	1.07e-05	0.000222	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—PTGS2—atherosclerosis	1.04e-05	0.000216	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—APOB—atherosclerosis	1.03e-05	0.000212	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GSTM1—atherosclerosis	1e-05	0.000207	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NAMPT—atherosclerosis	9.98e-06	0.000206	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—LIPC—atherosclerosis	9.92e-06	0.000205	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—APOC3—atherosclerosis	9.86e-06	0.000204	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—LPL—atherosclerosis	9.83e-06	0.000203	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—LDLR—atherosclerosis	9.8e-06	0.000202	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—GPX1—atherosclerosis	9.59e-06	0.000198	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CETP—atherosclerosis	9.57e-06	0.000198	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CD36—atherosclerosis	9.34e-06	0.000193	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—SCARB1—atherosclerosis	9.17e-06	0.000189	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—MTHFR—atherosclerosis	8.85e-06	0.000183	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PPARA—atherosclerosis	8.68e-06	0.000179	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HMGCR—atherosclerosis	8.66e-06	0.000179	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—AGT—atherosclerosis	8.41e-06	0.000174	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—APOE—atherosclerosis	8.24e-06	0.00017	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—CAV1—atherosclerosis	8.16e-06	0.000169	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—APOA1—atherosclerosis	8.14e-06	0.000168	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ABCA1—atherosclerosis	7.72e-06	0.000159	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PIK3CG—atherosclerosis	7.43e-06	0.000153	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PPARG—atherosclerosis	7.18e-06	0.000148	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—INS—atherosclerosis	7.04e-06	0.000145	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—HMOX1—atherosclerosis	6.62e-06	0.000137	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—ALB—atherosclerosis	6.45e-06	0.000133	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—APOB—atherosclerosis	6.34e-06	0.000131	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—NOS3—atherosclerosis	6.17e-06	0.000127	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GSTM1—atherosclerosis	6.17e-06	0.000127	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—LPL—atherosclerosis	6.05e-06	0.000125	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—GPX1—atherosclerosis	5.91e-06	0.000122	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CD36—atherosclerosis	5.75e-06	0.000119	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—PTGS2—atherosclerosis	5.64e-06	0.000117	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—MTHFR—atherosclerosis	5.45e-06	0.000113	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PPARA—atherosclerosis	5.35e-06	0.00011	CbGpPWpGaD
Topotecan—ABCG2—Metabolism—AKT1—atherosclerosis	5.25e-06	0.000108	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—AGT—atherosclerosis	5.18e-06	0.000107	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—APOE—atherosclerosis	5.08e-06	0.000105	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—CAV1—atherosclerosis	5.03e-06	0.000104	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—APOA1—atherosclerosis	5.02e-06	0.000104	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PIK3CG—atherosclerosis	4.58e-06	9.46e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PPARG—atherosclerosis	4.42e-06	9.13e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—INS—atherosclerosis	4.34e-06	8.95e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—ALB—atherosclerosis	3.98e-06	8.21e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—NOS3—atherosclerosis	3.8e-06	7.85e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—PTGS2—atherosclerosis	3.48e-06	7.18e-05	CbGpPWpGaD
Topotecan—ABCB1—Metabolism—AKT1—atherosclerosis	2.84e-06	5.86e-05	CbGpPWpGaD
Topotecan—CYP3A4—Metabolism—AKT1—atherosclerosis	1.75e-06	3.61e-05	CbGpPWpGaD
